These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 37497395)
1. Modeling vaccination coverage during the 2022 central Ohio measles outbreak: a cross-sectional study. Martoma RA; Washam M; Martoma JC; Cori A; Majumder MS Lancet Reg Health Am; 2023 Jul; 23():100533. PubMed ID: 37497395 [TBL] [Abstract][Full Text] [Related]
2. Epidemiologic Analysis of a Postelimination Measles Outbreak in Central Ohio, 2022-2023. Martoma RA; Washam M; Omar H; Martoma AR; De Souza R; Kumar S; Sege RD; Ricotta EE; Majumder MS JAMA Netw Open; 2024 Aug; 7(8):e2429696. PubMed ID: 39186272 [TBL] [Abstract][Full Text] [Related]
3. The effect of heterogeneity in uptake of the measles, mumps, and rubella vaccine on the potential for outbreaks of measles: a modelling study. Glasser JW; Feng Z; Omer SB; Smith PJ; Rodewald LE Lancet Infect Dis; 2016 May; 16(5):599-605. PubMed ID: 26852723 [TBL] [Abstract][Full Text] [Related]
4. Estimating time-varying cholera transmission and oral cholera vaccine effectiveness in Haiti and Cameroon, 2021-2023. Hulland EN; Charpignon ML; El Hayek GY; Zhao L; Desai AN; Majumder MS medRxiv; 2024 Aug; ():. PubMed ID: 39185512 [TBL] [Abstract][Full Text] [Related]
5. Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. van Boven M; Kretzschmar M; Wallinga J; O'Neill PD; Wichmann O; Hahné S J R Soc Interface; 2010 Nov; 7(52):1537-44. PubMed ID: 20392713 [TBL] [Abstract][Full Text] [Related]
6. A Measles Outbreak in an Underimmunized Amish Community in Ohio. Gastañaduy PA; Budd J; Fisher N; Redd SB; Fletcher J; Miller J; McFadden DJ; Rota J; Rota PA; Hickman C; Fowler B; Tatham L; Wallace GS; de Fijter S; Parker Fiebelkorn A; DiOrio M N Engl J Med; 2016 Oct; 375(14):1343-1354. PubMed ID: 27705270 [TBL] [Abstract][Full Text] [Related]
7. Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study. Winter AK; Lambert B; Klein D; Klepac P; Papadopoulos T; Truelove S; Burgess C; Santos H; Knapp JK; Reef SE; Kayembe LK; Shendale S; Kretsinger K; Lessler J; Vynnycky E; McCarthy K; Ferrari M; Jit M Lancet Glob Health; 2022 Oct; 10(10):e1412-e1422. PubMed ID: 36113527 [TBL] [Abstract][Full Text] [Related]
8. Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States. Lo NC; Hotez PJ JAMA Pediatr; 2017 Sep; 171(9):887-892. PubMed ID: 28738137 [TBL] [Abstract][Full Text] [Related]
9. Measles, mumps, rubella prevention: how can we do better? Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442 [TBL] [Abstract][Full Text] [Related]
10. Factors Associated With Measles Transmission in the United States During the Postelimination Era. Gastañaduy PA; Funk S; Lopman BA; Rota PA; Gambhir M; Grenfell B; Paul P JAMA Pediatr; 2020 Jan; 174(1):56-62. PubMed ID: 31738391 [TBL] [Abstract][Full Text] [Related]
11. Impact of Public Health Responses During a Measles Outbreak in an Amish Community in Ohio: Modeling the Dynamics of Transmission. Gastañaduy PA; Funk S; Paul P; Tatham L; Fisher N; Budd J; Fowler B; de Fijter S; DiOrio M; Wallace GS; Grenfell B Am J Epidemiol; 2018 Sep; 187(9):2002-2010. PubMed ID: 29635277 [TBL] [Abstract][Full Text] [Related]
12. The role of vaccination coverage, individual behaviors, and the public health response in the control of measles epidemics: an agent-based simulation for California. Liu F; Enanoria WT; Zipprich J; Blumberg S; Harriman K; Ackley SF; Wheaton WD; Allpress JL; Porco TC BMC Public Health; 2015 May; 15():447. PubMed ID: 25928152 [TBL] [Abstract][Full Text] [Related]
13. Characterizing the impact of spatial clustering of susceptibility for measles elimination. Truelove SA; Graham M; Moss WJ; Metcalf CJE; Ferrari MJ; Lessler J Vaccine; 2019 Jan; 37(5):732-741. PubMed ID: 30579756 [TBL] [Abstract][Full Text] [Related]
14. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis. Trentini F; Poletti P; Merler S; Melegaro A Lancet Infect Dis; 2017 Oct; 17(10):1089-1097. PubMed ID: 28807627 [TBL] [Abstract][Full Text] [Related]
15. Measles Population Immunity Profiles: Updated Methods and Tools. Li X; Goodson JL; Perry RT Vaccines (Basel); 2024 Aug; 12(8):. PubMed ID: 39204060 [TBL] [Abstract][Full Text] [Related]
16. Identifying postelimination trends for the introduction and transmissibility of measles in the United States. Blumberg S; Enanoria WT; Lloyd-Smith JO; Lietman TM; Porco TC Am J Epidemiol; 2014 Jun; 179(11):1375-82. PubMed ID: 24786800 [TBL] [Abstract][Full Text] [Related]
17. Sub-national variation in measles vaccine coverage and outbreak risk: a case study from a 2010 outbreak in Malawi. Kundrick A; Huang Z; Carran S; Kagoli M; Grais RF; Hurtado N; Ferrari M BMC Public Health; 2018 Jun; 18(1):741. PubMed ID: 29902976 [TBL] [Abstract][Full Text] [Related]
18. Investigation of a Measles Outbreak in China to Identify Gaps in Vaccination Coverage, Routes of Transmission, and Interventions. Zheng X; Zhang N; Zhang X; Hao L; Su Q; Wang H; Meng K; Zhang B; Liu J; Wang H; Luo H; Li L; Li H; Ma C PLoS One; 2015; 10(7):e0133983. PubMed ID: 26208216 [TBL] [Abstract][Full Text] [Related]
19. Estimating the number of US children susceptible to measles resulting from COVID-19-related vaccination coverage declines. Gambrell A; Sundaram M; Bednarczyk RA Vaccine; 2022 Jul; 40(32):4574-4579. PubMed ID: 35728989 [TBL] [Abstract][Full Text] [Related]
20. Measles outbreak investigation in Guji zone of Oromia Region, Ethiopia. Belda K; Tegegne AA; Mersha AM; Bayenessagne MG; Hussein I; Bezabeh B Pan Afr Med J; 2017; 27(Suppl 2):9. PubMed ID: 28983397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]